Future studies should include broader CD36 gene analysis, extended haplotype exploration, gene–gene interaction investigation, and multiomic or epigenetic approaches to elucidate mechanisms linking CD36 with metabolic dysfunction and atherogenesis in T2DM. Here, CD36 is linked to type 2 diabetes mellitus.